ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026
Globe Newswire•03/08/2026•16:00 ET
0
Whiz Insights
Company to host investor conference call and webcast at 4:30 p.m. ET.
Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the second quarter ended June 30, 2026, and provide corporate updates on August 13, 2026.
Get started
Create a free account to read the full story.